Optimizing insulin sensitivity assessment using the minimal model in chronic heart failure

Hormone and Metabolic Research

Volumn 37, Issue 2, 2005, Pages 106-110

  Doehner, W ^a   Anker, S D ^a,b   Godsland, I F ^c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Chronic heart failure; Insulin sensitivity; Minimal model

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; WARFARIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HEART FAILURE; HUMAN; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; METHODOLOGY; MODEL; PRIORITY JOURNAL;

BLOOD GLUCOSE; CHRONIC DISEASE; FEMALE; GLUCOSE TOLERANCE TEST; HEART FAILURE, CONGESTIVE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; MODELS, BIOLOGICAL;

EID: 15944368145     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-861175     Document Type: Article

References (14)

1. Swan JW, Anker SD, Walton C, Godsland IF, Clark AL, Leyva F et al. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Amer Coll Cardiol 1997; 30: 527-532
2. Doehner W, Rauchhaus M, Godsland IF, Egerer K, Niebauer J, Sharma R et al. Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha. Int J Cardiol 2002; 83: 73-81
3. Doehner W, Godsland IF, Rauchhaus M, Ponikowski PP, Coats AJS, Anker SD. Insulin resistance and survival in chronic heart failure. J Am Coll Cardiol 2003; 41 (suppl A): 158A
4. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol 1979; 236: E667-E677
5. Swan J, Walton C, Godsland IF. Assessment of insulin sensitivity in man: a comparison of minimal model and euglycaemic clamp derived measures in health and heart failure. Clin Sci 1994; 86: 317-322
6. Godsland IF. The minimal model: an evolving methodology. Clin Sci 2003; 105: 531-532
7. Perez-Martin A, Raynaud E, Hentgen C, Bringer J, Mercier J, Brun JF. Simplified measurement of insulin sensitivity with the minimal model procedure in type 2 diabetic patients without measurement of insulinemia. Horm Metab Res. 2002; 34: 102-106
8. Welch S, Gebhart S, Bergman R, Philips L. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab 1990; 71: 1508-1518
9. Coates PA, Ollerton RL, Luzio SD, Ismail IS, Owens DR. Reduced sampling protocols in estimation of insulin sensitivity and glucose effectiveness using the minimal model in NIDDM. Diabetes 1993; 42: 1635-1641
10. Caumo AC, Cobelli C. Hepatic glucose production during the labelled IVGTT: estimation by deconvolution with a new minimal model. Am J Physiol 1993; 264: E829-E841
11. Godsland IF, Walton C. Maximising the success rate of minimal model insulin sensitivity measurement in humans: the importance of basal glucose levels. Clin Sci 2001; 101: 1-9
12. Swan JW, Walton C, Godsland IF, Clark AL, Coats AJS, Oliver MF. Insulin resistance in chronic heart failure. Eur Heart J 1994; 15: 1528-1532
13. Suskin N, McKelvie RS, Burns RJ, Latini R, Pericak D, Probstfield J et al. Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J 2000; 21: 1368-1375
14. Paolisso G, De Rui S, Matrrazzo G, Verza M, Varricchio M, D'Onofrio F. Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure. Metabolism 1991; 40: 972-977